The largest longitudinal study to date shows that common and inexpensive blood pressure medications may prolong survival for pancreatic cancer patients. 

Combining epidemiological mapping and community outreach, researchers target educational interventions to populations in Philadelphia at highest risk for the disease. 

Researching ways to achieve better health outcomes and self-awareness. 

Immune cells could be doing much more than we think in protecting our eyes – Jefferson researchers uncover new details. 

New Research shows that women treated for melanoma have twice the mortality rate of men when given two immunotherapies at one time. 

In a first-ever study, a unique spiritual practice called orgasmic meditation, has been found to produce a distinctive pattern of brain function.

Learning how a flexible, inexpensive and non-invasive tool can be used to diagnose and stage common diseases from cancer to heart attack.

Examining addiction’s impact on family members and the importance of cultural humility.

Eight years after being named President of Thomas Jefferson University and CEO of Jefferson Health, Stephen K. Klasko, MD, MBA, will retire from his position, effective December 31, 2021.